MedVellum
MedVellum
Back to Library
Palliative Care
Oncology
Internal Medicine
General Practice

Nausea and Vomiting in Palliative Care

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Faeculent Vomiting (Obstruction)
  • Severe Headache / Visual Change (Raised ICP)
  • Coffee Ground Vomiting (GI Bleed)
  • Severe Dehydration / AKI
Overview

Nausea and Vomiting in Palliative Care

1. Clinical Overview

Summary

Nausea and vomiting are common, distressing symptoms in palliative care, affecting up to 70% of patients with advanced cancer. Management relies on the principle of Mechanism-Based Prescribing: identifying the likely physiological trigger (e.g., chemical, mechanical, vestibular, or cortical) and selecting an anti-emetic that targets the specific receptors involved. Common causes include opioids, hypercalcaemia, constipation, gastric stasis, and bowel obstruction. The subcutaneous route (Syringe Driver) is often required when oral absorption is compromised. [1,2]

Key Facts

  • Mechanism-Based Approach: Don't just guess. Ask "Why are they vomiting?"
  • The Vomiting Centre (VC): Located in the medulla. It integrates inputs from the Chemoreceptor Trigger Zone (CTZ), Vestibular apparatus, GI tract, and Cortex.
  • Prokinetics in Obstruction: Metoclopramide/Domperidone stimulate gastric emptying. They are CONTRAINDICATED in complete mechanical bowel obstruction (risk of perforation/colic).
  • Syringe Drivers: Continuous Subcutaneous Infusion (CSCI) is the gold standard for stable symptom control in the terminal phase.

Clinical Pearls

The "Cyclizine + Metoclopramide" Clash: Avoid combining these. Metoclopramide is prokinetic (pushes gut forward). Cyclizine is anticholinergic (relaxes gut). They antagonise each other pharmacologically.

Levomepromazine: The "Broad Spectrum" heavy hitter. It blocks Dopamine, Histamine, Acetylcholine, and Serotonin receptors. Use it as second-line or rescue when single agents fail, but beware of sedation.

Opioid Nausea: Usually transient (first 3-5 days). Haloperidol is first line. Warn patients they will get used to it (tolerance develops to nausea, unlike constipation).

Steroids for Obstruction: Dexamethasone can reduce peri-tumoural oedema in bowel obstruction, potentially turning a complete obstruction into a partial one.


2. Epidemiology

Prevalence

  • Advanced Cancer: 40-70%.
  • Opioid Naive: 30-40% experience nausea on initiation.
  • End Stage Renal Failure: High prevalence (uraemia).

3. Pathophysiology

The Four Main Inputs to the Vomiting Centre

Input SourceStimuliKey ReceptorsDrug Choices
1. CTZ (Chemoreceptor Trigger Zone)Blood-borne toxins: Opioids, Digoxin, Uraemia, Hypercalcaemia, Chemo.D2, 5HT3Haloperidol, Ondansetron, Levomepromazine
2. GI Tract (Vagus Nerve)Gastric Stasis, Squashed Stomach syndrome, Constipation, Irritation (NSAIDs).D2, 5HT4Metoclopramide, Domperidone
3. Vestibular SystemMotion, Base of skull mets, Opioids (sensitise).H1, M1Cyclizine, Hyoscine
4. CortexAnxiety, Pain, Anticipatory nausea, Raised ICP (partial).GABA, H1Lorazepam, Dexamethasone, Cyclizine

4. Clinical Presentation

Assessment by History


Timing
Post-prandial (early): Gastric stasis / Squashed stomach. Early Morning: Raised Intracranial Pressure (ICP).
Content
Undigested food: Gastric stasis / Outlet obstruction. Bilious/Faeculent: Bowel Obstruction. Coffee Grounds: GI Bleed.
Triggers
Movement (Vestibular), Sight/Smell of food (Central).
5. Clinical Examination

Signs

  • Abdomen: Distension (ascites/obstruction?), Bowel sounds (Tinkling?), Tenderness, Hepatosplenomegaly.
  • Rectal (PR): Impacted faeces (Constipation is a major, reversible cause).
  • Neurological: Papilloedema, Nystagmus.
  • Hydration: Mucous membranes, skin turgor.

6. Investigations

"Appropriate" Investigation

In palliative care, only investigate if the result will change management.

  • Blood: Calcium (Correctable?), Urea/Creatinine (Renal failure drug accumulation?), LFTs.
  • Abdominal X-Ray: If obstruction suspected.
  • CT Scan: Only if considering surgical/stenting intervention or uncertain diagnosis.

7. Management

Management Algorithm (Mechanism-Based)

           NAUSEA ASSESSMENT
           (Identify Cause)
                  ↓
      ┌───────────┼───────────┐
  CHEMICAL    GASTRIC      OBSTRUCTED    BRAIN METS
 (Opioids,    STASIS       BOWEL or      or VESTIB
  Metabolic)  (Fullness)   VISCERAL      (Motion)
      ↓           ↓           ↓             ↓
 HALOPERIDOL  METOCLOP-    CYCLIZINE     CYCLIZINE
 (or Levo)    RAMIDE       (or Hyoscine  (or Dexameth)
                           Butylbromide)

1. General Measures

  • Treat Constipation (Laxatives).
  • Treat Hypercalcaemia (Bisphosphonates if appropriate).
  • Treat Thrush (Oral antifungals).
  • Small, frequent meals. Reduce strong odours.

2. Pharmacotherapy (First Line)

CauseFirst Line DrugDose (Oral/SC)Mechanism
Chemical (Opioids/Renal)Haloperidol1.5-3mg OD/BDD2 Antagonist (CTZ)
Gastric StasisMetoclopramide10mg TDSProkinetic (Gastric)
Bowel ObstructionCyclizine50mg TDSAnticholinergic (relaxes gut)
Raised ICPDexamethasone8-16mg AMReduces Oedema (plus Cyclizine)
MotionCyclizine50mg TDSH1 Antagonist

3. Second Line (Broad Spectrum)

  • Levomepromazine:
    • Neuroleptic with affinity for D2, H1, M1, 5HT2.
    • Very effective but sedating.
    • Dose: 6.25mg - 25mg SC OD (start low).

4. Malignant Bowel Obstruction

If inoperable:

  • Stop Prokinetics (Metoclopramide) if colic present.
  • Analgesia: Opioids for pain.
  • Anti-secretory:
    • Hyoscine Butylbromide (Buscopan): Reduces smooth muscle spasm and secretions. 60-120mg/24h CSCI.
    • Octreotide: Somatostatin analogue. Powerful reduction in GI secretions.

5. Syringe Drivers (CSCI)

  • If vomiting prevents oral absorption.
  • Combine drugs carefully (compatibility).
  • Common Mix: Morphine + Midazolam + Haloperidol/Levomepromazine + Glycopyrronium/Buscopan.

8. Complications
  • Dehydration / AKI: Worsens nausea (uraemia).
  • Drug Toxicity: Accumulation of opioids requiring dose reduction.
  • Oral Route Failure: Loss of pain control.

9. Prognosis and Outcomes
  • Most nausea can be well controlled with correct drug selection.
  • Refractory cases may require sedation (Midazolam/Levomepromazine) in terminal phase.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
Palliative Care FormularyPCF / BNFGold standard dosing and compatibility data.
MASCCCancer CareGuidelines on chemotherapy-induced nausea (CINV).
Bowel ObstructionNICEUse of Octreotide and Steroids in malignant obstruction.

Landmark Knowledge

1. The Levomepromazine Rescue

  • Studies consistently show Levomepromazine is effective in >80% of refractory cases, acting as a "chemical lobotomy" for the vomiting centre.

2. Haloperidol for Opioid Nausea

  • Hardy et al. confirmed Haloperidol (D2) mimics the mechanism of opioid emesis (CTZ stimulation), supporting its use as first line.

11. Patient and Layperson Explanation

Why am I feeling sick?

There are many reasons. It can be the painkillers (morphine), the cancer releasing chemicals into the blood, constipation, or the stomach not emptying properly.

Will it stop?

Yes. We have very effective medicines. Because different things cause sickness, we might need to try one or two to find the specific one that blocks the right "button" in your brain.

Do I need injections?

If you are vomiting up the tablets, they won't work. We can put a small battery-operated pump (syringe driver) under the skin to trickle the medicine in continuously. This works much better and stops you needing injections every few hours.


12. References

Primary Sources

  1. Twycross R, Wilcock A. Palliative Care Formulary (PCF). 7th/8th Ed.
  2. NICE Clinical Support Guideline (CSG4). Nausea and vomiting in adults in the last days of life. 2013.
  3. Glare P, et al. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004;12:432-440.

13. Examination Focus

Common Exam Questions

  1. Palliative Care: "Anti-emetic for opioid-induced nausea?"
    • Answer: Haloperidol (or Ondansetron/Metoclopramide 2nd line, but Haloperidol standard).
  2. Pharmacology: "Why avoid Cyclizine and Metoclopramide together?"
    • Answer: Pharmacological antagonism (Prokinetic vs Anticholinergic). If mixed in syringe driver, they also crystallise.
  3. Oncology: "Vomiting with Faeculent nature. Drug?"
    • Answer: Bowel Obstruction. Use Cyclizine or Levomepromazine. Stop Metoclopramide.
  4. Medicine: "Mechanism of Ondansetron?"
    • Answer: 5HT3 Antagonist. (Best for Chemo/Post-op, less useful for general palliative causes but used).

Viva Points

  • Levomepromazine: Know the receptor profile (broad spectrum).
  • Prokinetics: Domperidone doesn't cross BBB (less extrapyramidal side effects than Metoclopramide).
  • H1 Receptors: Found in Vestibular nuclei AND Vomiting Centre. Hence Cyclizine works for motion sickness and raised ICP (vestibular component).

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Faeculent Vomiting (Obstruction)
  • Severe Headache / Visual Change (Raised ICP)
  • Coffee Ground Vomiting (GI Bleed)
  • Severe Dehydration / AKI

Clinical Pearls

  • **Opioid Nausea**: Usually transient (first 3-5 days). Haloperidol is first line. Warn patients they will get used to it (tolerance develops to nausea, unlike constipation).
  • **Steroids for Obstruction**: Dexamethasone can reduce peri-tumoural oedema in bowel obstruction, potentially turning a complete obstruction into a partial one.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines